Published in Proc R Soc Med on July 01, 1972
Recent insights into C3 glomerulopathy. Nephrol Dial Transplant (2013) 1.21
Dense deposit disease and C3 glomerulopathy. Semin Nephrol (2013) 0.98
Measles infection. Involvement of the complement system. Clin Exp Immunol (1976) 0.91
Systemic lupus erythematosus with widespread subcutaneous fat calcification. Proc R Soc Med (1974) 0.79
Partial lipodystrophy in coeliac disease. Gut (1990) 0.75
Current concepts in C3 glomerulopathy. Indian J Nephrol (2014) 0.75
Partial lipodystrophy with nephrotic syndrome. Postgrad Med J (1978) 0.75
The interrelationship between hypocomplementaemia, partial lipodystrophy and mesangiocapillary glomerulonephritis. Postgrad Med J (1976) 0.75
Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients. J Clin Invest (1967) 4.45
Serum C'3 lytic system in patients with glomerulonephritis. Science (1969) 4.44
Chronic glomerulonephritis associated with low serum complement activity (chronic hypocomplementemic glomerulonephritis). Medicine (Baltimore) (1970) 1.94
Continuing C3 breakdown after bilateral nephrectomy in patients with membrano-proliferative glomerulonephritis. J Clin Invest (1971) 1.31
[2 cases of membrano-proliferative glomerulonephritis associated with partial lipodistrophy of facio-truncal type]. J Urol Nephrol (Paris) (1970) 1.00
[Nephropathies in progressive lipodystrophy or Barraquer-Simons disease]. Ann Pediatr (Paris) (1965) 0.98
Haematemesis and melaena, with special reference to factors influencing the outcome. Br Med J (1970) 4.31
Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med (1979) 3.02
Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome. Lancet (1976) 3.00
Successful treatment of middle aged and elderly patients with end stage renal disease. Br Med J (Clin Res Ed) (1983) 2.88
Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia. J Clin Invest (1974) 2.81
Inhibition of immune precipitation by complement. Clin Exp Immunol (1980) 2.72
The role of complement and its receptor in the elimination of immune complexes. N Engl J Med (1986) 2.63
Complement studies in membrano-proliferative glomerulonephritis. Clin Exp Immunol (1972) 2.60
10 years' experience with regular haemodialysis and renal transplantation. Arch Dis Child (1980) 2.56
The complement abnormalities of lipodystrophy. N Engl J Med (1976) 2.40
Value of immune-complex assays in diagnosis and management. Lancet (1978) 2.39
Relapses in Wegener's granulomatosis: the role of infection. Br Med J (1980) 2.29
Gastric cancer simulating benign gastric ulcer. Br J Surg (1969) 2.27
Remission of myasthenia gravis following plasma-exchange. Lancet (1976) 2.25
Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways. Clin Exp Immunol (1982) 2.20
The effect of defibrination on nephrotoxic serum nephritis in rabbits. Clin Sci (1972) 2.11
Glomerular deposition of properdin in Henoch-Schönlein syndrome and idiopathic focal nephritis. Br Med J (1973) 2.07
Wegener's granulomatosis: observations on 18 patients with severe renal disease. Q J Med (1983) 2.07
Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia. Lancet (1973) 2.00
Role of C3b in the breakdown of C3 in hypocomplementaemic mesangiocapillary glomerulonephritis. Lancet (1973) 1.93
Letter: Rotavirus infections in a maternity unit. Lancet (1975) 1.92
Enhanced allergic tissue injury in Goodpasture's syndrome by intercurrent bacterial infection. Br Med J (1977) 1.92
Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis. Lancet (1983) 1.87
The silver swaddler. Device for preventing hypothermia in the newborn. Lancet (1968) 1.79
The role of polymorphonuclear leucocytes in the autologous phase of nephrotoxic nephritis. Clin Exp Immunol (1975) 1.75
Non-shivering thermogenesis and brown adipose tissue in the human new-born infant. Nature (1965) 1.74
Plasma-exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis. Lancet (1977) 1.71
Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis. Am J Med (1983) 1.70
Studies of serum complement in the hypocomplementaemic nephritides. Clin Exp Immunol (1974) 1.67
A quantitative evaluation of anticoagulants in experimental nephrotoxic nephritis. Clin Exp Immunol (1975) 1.61
Murine lupus monoclonal antibodies define five epitopes on two different Sm polypeptides. Immunology (1986) 1.54
Gastroscopy with biopsy and cytological sampling under direct vision. Br Med J (1968) 1.53
The role of C3 in the autologous phase of nephrotoxic nephritis. Clin Exp Immunol (1976) 1.51
Anti-ssDNA and antinuclear antibodies in human malaria. Clin Exp Immunol (1982) 1.49
Genes encoding the beta-chains of HLA-DR7 and HLA-DQw2 define major susceptibility determinants for idiopathic nephrotic syndrome. Clin Sci (Lond) (1990) 1.49
Complement, the immune-complex lattice, and the pathophysiology of complement-deficiency syndromes. Lancet (1983) 1.48
The immunogloblin nature of nephritic factor (NeF). Clin Exp Immunol (1978) 1.47
Monoclonal antibodies to the Sjögren's syndrome associated antigen SS-B (La). J Immunol Methods (1985) 1.46
Albumin metabolism in chronic renal failure. Clin Sci (1970) 1.46
Ropivacaine in neonates and infants: a population pharmacokinetic evaluation following single caudal block. Paediatr Anaesth (2004) 1.44
Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol (1990) 1.44
The immunogenetic basis of autoimmunity. Autoimmunity (1990) 1.42
A review of the literature on cocaine abuse in pregnancy. Nurs Res (1991) 1.40
Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int (1991) 1.40
Percutaneous transluminal renal angioplasty in patients with renal failure. Q J Med (1993) 1.39
Delayed removal of renal-bound antigen in decomplemented rabbits with acute serum sickness. Clin Exp Immunol (1978) 1.38
Virus infection induces redistribution and membrane localization of the nuclear antigen La (SS-B): a possible mechanism for autoimmunity. Clin Exp Immunol (1989) 1.36
Zinc and small babies. Lancet (1981) 1.34
High versus "low" dose corticosteroids in recipients of cadaveric kidneys: prospective controlled trial. Br Med J (Clin Res Ed) (1983) 1.34
Idiopathic hypoglycaemia in sibs with morphological evidence of nesidioblastosis of the pancreas. Arch Dis Child (1976) 1.33
Intestinal permeability and lactose hydrolysis in human rotaviral gastroenteritis assessed simultaneously by non-invasive differential sugar permeation. Eur J Clin Invest (1986) 1.33
Gastrointestinal permeability changes in the preterm neonate. Arch Dis Child (1982) 1.32
Immunity deficiency in pathogenesis of glomerulonephritis. Lancet (1974) 1.31
Seasonal nephrotic syndrome. Description and immunological findings. Clin Allergy (1975) 1.29
Complement deficiency and nephritis. A report of a family. Lancet (1980) 1.27
A disposable catheter-tip transducer for continuous measurement of blood oxygen tension in vivo. Biomed Eng (1971) 1.25
Strong association between HLA-DRW2 and antibody-mediated Goodpasture's syndrome. Lancet (1978) 1.23
Defibrination with ancrod in nephrotoxic nephritis in rabbits. Kidney Int (1976) 1.23
Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody. Clin Exp Immunol (1976) 1.22
The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol (1978) 1.21
Isolated glomerulonephritis with mesangial IgA deposits. Br Med J (1975) 1.20
Gel-electrophoretic identification of hen brain neurotoxic esterase, labelled with tritiated di-isopropyl phosphorofluoridate. Biochem J (1981) 1.20
Metabolic reference standards for the neonate. Pediatrics (1967) 1.19
Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis. Clin Exp Immunol (1981) 1.19
Antecedent moisture and seasonal precipitation influence the response of canopy-scale carbon and water exchange to rainfall pulses in a semi-arid grassland. New Phytol (2006) 1.18
Adult-onset minimal change nephrotic syndrome: a long-term follow-up. Kidney Int (1986) 1.18
Dianthins, ribosome-damaging proteins with anti-viral properties from Dianthus caryophyllus L. (carnation). Biochem J (1981) 1.18
Observations on calcium metabolism in the nephrotic syndrome. Q J Med (1967) 1.17
Clinical and immunological evolution of oligoanuric anti-GBM nephritis treated by haemodialysis. Lancet (1986) 1.16
C3 breakdown by serum from patients with acute post-streptococcal nephritis. Lancet (1972) 1.16
Vasculitis affecting the kidney: presentation, histopathology and long-term outcome. Q J Med (1984) 1.15
The effects of defibrination with ancrod in experimental allergic glomerular injury. Clin Exp Immunol (1975) 1.15
Weight minus extracellular fluid as metabolic reference standard in newborn baby. Arch Dis Child (1971) 1.15
Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology (1994) 1.15
Alllergic response to glomerular basement membrane in patients with glomerulonephritis. Lancet (1972) 1.14
Antibodies to La, Jo-1, nRNP and Sm detected by multi-track immunoblotting using a novel filter holder: a comparative study with counterimmunoelectrophoresis and immunodiffusion using sera from patients with systemic lupus erythematosus and Sjögren's syndrome. J Immunol Methods (1986) 1.14
Anti-La monoclonal antibodies recognizing epitopes within the RNA-binding domain of the La protein show differential capacities to immunoprecipitate RNA-associated La protein. Eur J Biochem (1995) 1.13
Total body calcium by whole body neutron activation: new technique for study of bone disease. Br Med J (1968) 1.12
Infection and immunosuppression. A study of the infective complications of 75 patients with immunologically-mediated disease. Q J Med (1982) 1.12
DNA-anti-DNA circulating complexes in the nephritis of systemic lupus erythematosus. Clin Exp Immunol (1981) 1.11
Guinea-pig nephrotoxic nephritis. I. The role of complement and polymorphonuclear leucocytes and the effect of antibody subclass and fragments in the heterologous phase. Clin Exp Immunol (1975) 1.11
Anti-glomerular basement membrane autoantibodies in the Brown Norway rat: detection by a solid-phase radioimmunoassay. J Immunol Methods (1983) 1.11
Systemic lupus with nephritis: a long-term study. Q J Med (1979) 1.11
Plasma exchange in myasthenia gravis. Lancet (1977) 1.10
Metabolic rate and temperature control in the human baby. Br Med Bull (1966) 1.09
The effect of excess dietary iodine on pregnant mares and foals. Vet Rec (1975) 1.08
Differentiation between allograft rejection and cyclosporin nephrotoxicity in renal-transplant recipients. Lancet (1985) 1.07
Metabolism of the third component of complement (C3) in normal human subjects. Clin Sci Mol Med (1974) 1.07
Expression of the SmB' splicing protein in rodent cells capable of following an alternative RNA splicing pathway. FEBS Lett (1989) 1.06
Why do patients with lupus nephritis die? Br Med J (Clin Res Ed) (1985) 1.06
Observations on blood pressure in newborn infants. Arch Dis Child (1965) 1.06
Metabolism of human beta 1H: studies in man and experimental animals. Clin Exp Immunol (1979) 1.05